drugset

drugset / Trial / NCT03967886

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

NCT03967886 ↗

Phase 3 Completed 170 enrolled Yooyoung Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

Timeline

Start: 2019-04-10
Primary completion: 2019-12-20
Completion: 2020-05-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esomeprazole	Small molecule	20 mg	—

Indications